RosellA
Natural health product licensed in Canada
- Licence holder
- Lallemand Health Solutions (Institut Rosell)
- NPN or DIN-HM
- 80129827
- Status
- Active licence
- Licence date
- 27 February 2024
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de titane, Croscarmellose de sodium, Mannitol, Dioxyde de silicium colloïdal, Amidon de maïs modifié, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of Probiotic. Helps to support female or vaginal health. Helps support a healthy vaginal microflora. Helps maintain vaginal microbiome health. Helps reduce vaginal pH to healthy levels. In combination with antifungal treatment, help delay/lengthen/improve relapse time for (recurrent) vulvovaginal candidiasis (VVC/rVVC). In combination with antifungal treatment, reduces clinical signs (itching, burning, pain during sexual intercourse, pain while urinating, vaginal discharge, smell, redness, swelling) of vulvovaginal candidiasis (VVC)/recurrent vulvovaginal candidiasis (rVVC). Helps to improve vaginal (microbiome) health in women with a history of vulvovaginal candidiasis (VVC)/recurrent vulvovaginal candidiasis (rVVC). Reduces clinical signs (redness, swelling) of vulvovaginal candidiasis (VVC)/ recurrent vulvovaginal candidiasis (VVC). Helps treat recurrent vulvovaginal candidiasis (rVVC) as an adjuvant to antimicrobial treatment. Helps improve treatment of bacterial vaginosis (BV) in combination with antimicrobial treatment.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80129827
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.